Advanced search
Publication Cover
Expert Review of Vaccines Volume 16, 2017 - Issue 11
Submit an article Journal homepage
422
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: a double-blind, randomized, parallel-controlled phase III clinical trial in China

Shi-Yuan WangDepartment of Public Health, Southeast University, Nanjing, PR ChinaView further author information
,
Shu-Zhen LiuDepartment of Respiratory Virus Vaccine, National Institutes for Food and Drug Control, Beijing, PR ChinaView further author information
,
Kai ChuVaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, PR ChinaView further author information
,
Yue ZhaoCorporate Representative, Jiangsu GDK Biotechnology Co., Ltd, Taizhou, PR ChinaView further author information
,
Feng-Cai ZhuVaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, PR ChinaView further author information
,
Yue-Mei HuVaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, PR ChinaView further author information
,
Fan-Yue MengVaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, PR ChinaView further author information
,
Jing-Xin LiVaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, PR ChinaView further author information
,
Li LuoDepartment of Public Health, Southeast University, Nanjing, PR ChinaView further author information
,
Jia-Ying YangDepartment of Public Health, Southeast University, Nanjing, PR ChinaView further author information
,
Pei LiuDepartment of Public Health, Southeast University, Nanjing, PR ChinaCorrespondence[email protected]
View further author information
&
Jun YuCorporate Representative, Jiangsu GDK Biotechnology Co., Ltd, Taizhou, PR ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1155-1169 | Received 16 Jun 2017, Accepted 29 Aug 2017, Published online: 18 Sep 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.